Pharmaceuticals, Biotechnology and Life Sciences
Enrollment Initiated in Phase 2 Trial Cohort Evaluating SY-1425 and Azacitidine in Genomically Defined Patients with Relapsed or Refractory Acute…
Announced completion of enrollment in Pfizer’s Phase 3 clinical trial evaluating rivipansel, the Company’s lead investigational drug candidate, in sickle…
– Company Continues to Expand its Gene Therapy Portfolio with the Addition of miniUSH2A Program – – Company to Host…
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM PLEASANTON, Calif.–(BUSINESS WIRE)–#CRM—Veeva Systems (NYSE:…
ZDNet and Nucleus Research also name Veeva a leader for continued innovation in Veeva CRM BARCELONA, Spain–(BUSINESS WIRE)–Veeva Systems (NYSE:…
Dermatology.com Supports Lower, Predictable Pricing for Many of Bausch Health’s Prescription Dermatology Products at Walgreens 9,500 Retail Pharmacies DEERFIELD, Ill.,…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc, a biotechnology company pioneering a new class of therapeutics based on its proprietary…
Conference Call Scheduled Today at 8:30 a.m. EDT LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that members…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trials Market Analysis by Phase (Phase I/II/III/IV), by Study Design (Interventional, Observational, Expanded Access), by Indication (Autoimmune,…